{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:05Z","timestamp":1761178385098,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.canrad.2009.08.144","type":"journal-article","created":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T05:37:35Z","timestamp":1257226655000},"page":"721-730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Curieth\u00e9rapie de prostate par iode 125\u00a0: facteurs pronostiques de longue dur\u00e9e de toxicit\u00e9 urinaire, digestive et sexuelle"],"prefix":"10.1016","volume":"13","author":[{"given":"J.","family":"Doyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Chamorey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mohammed Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ginot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ferre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Quintens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Hannoun-L\u00e9vi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2009.08.144_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2004.12.068","article-title":"Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity","volume":"62","author":"Allen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8140(00)00306-6","article-title":"ESTRO\/EAU\/EORTC recommendations on permanent seed implantation for localized prostate cancer","volume":"57","author":"Ash","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2009.08.144_bib3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0022-5347(01)66985-4","article-title":"Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1\/T2\u00a0prostatic carcinoma","volume":"154","author":"Blasko","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2009.08.144_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.radonc.2006.11.006","article-title":"Side effects of permanent I125\u00a0prostate seed implants in 667\u00a0patients treated in Leeds","volume":"82","author":"Bottomley","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2009.08.144_bib5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0360-3016(03)00210-4","article-title":"Urinary symptom flare following I-125\u00a0prostate brachytherapy","volume":"56","author":"Cesaretti","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ijrobp.2007.11.056","article-title":"Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie\/Cochin Hospital\/Necker Hospital group on 809\u00a0patients","volume":"71","author":"Cosset","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canrad.2007.05.003","article-title":"Analyse clinique et\u00a0dosim\u00e9trique de\u00a0469\u00a0patients trait\u00e9s en\u00a0France en\u00a02005\u00a0par\u00a0implantation prostatique de\u00a0grains d\u2019iode 125\u00a0IsoSeed Bebig\u00a0: rapport pour\u00a0le\u00a0Comit\u00e9 \u00e9conomique des\u00a0produits de\u00a0sant\u00e9 (CEPS)","volume":"11","author":"Cosset","year":"2007","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2009.08.144_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.juro.2007.08.136","article-title":"Long-term urinary sequelae following 125iodine prostate brachytherapy","volume":"179","author":"Crook","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2009.08.144_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.10657","article-title":"Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era","volume":"95","author":"D\u2019Amico","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2009.08.144_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0360-3016(00)00632-5","article-title":"Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer","volume":"48","author":"Gelblum","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(99)00176-5","article-title":"Urinary morbidity following ultrasound-guided transperineal prostate seed implantation","volume":"45","author":"Gelblum","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2006.06.004","article-title":"Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050\u00a0patients with clinical T1-T2\u00a0prostate cancer","volume":"80","author":"Guedea","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2009.08.144_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1464-410X.2006.05887.x","article-title":"Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy","volume":"97","author":"Gutman","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2009.08.144_bib14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1464-410X.2004.4737h.x","article-title":"Urinary morbidity after 125I brachytherapy of the prostate","volume":"93","author":"Henderson","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2009.08.144_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0360-3016(01)02811-5","article-title":"Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy","volume":"53","author":"Kang","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.clon.2006.02.007","article-title":"Prediction of urinary symptoms after 125iodine prostate brachytherapy","volume":"18","author":"Kelly","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2009.08.144_bib17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Urinary Symptom Flare in 712 (125)I prostate brachytherapy patients: Long-Term Follow-Up","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712\u00a0consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0360-3016(03)00627-8","article-title":"Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality","volume":"57","author":"Kollmeier","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-006-0083-1","article-title":"Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer","volume":"24","author":"Machtens","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.canrad.2009.08.144_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0360-3016(01)02675-X","article-title":"Erectile function after permanent prostate brachytherapy","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(99)00525-8","article-title":"Temporal resolution of urinary morbidity following prostate brachytherapy","volume":"47","author":"Merrick","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1464-410X.2005.05346.x","article-title":"Brachytherapy-related dysuria","volume":"95","author":"Merrick","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2009.08.144_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0360-3016(03)00501-7","article-title":"Late rectal function after prostate brachytherapy","volume":"57","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0360-3016(03)01440-8","article-title":"Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapy","volume":"58","author":"Merrick","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1464-410X.2006.06248.x","article-title":"Brachytherapy in men aged < or=54\u00a0years with clinically localized prostate cancer","volume":"98","author":"Merrick","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2009.08.144_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0360-3016(99)00069-3","article-title":"American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer","volume":"44","author":"Nag","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brachy.2007.03.003","article-title":"The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry","volume":"6","author":"Neill","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2009.08.144_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2005.06.035","article-title":"The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy","volume":"64","author":"Niehaus","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10147-006-0584-3","article-title":"Serial changes of international prostate symptom score following I-125\u00a0prostate brachytherapy","volume":"11","author":"Ohashi","year":"2006","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.canrad.2009.08.144_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.brachy.2007.08.007","article-title":"Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume","volume":"6","author":"Petit","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2009.08.144_bib32","doi-asserted-by":"crossref","unstructured":"Pickles T, Keyes M, Morris WJ. and On behalf of the Prostate Outcomes and Provincial Prostate Brachytherapy Program. Brachytherapy or Conformal External Radiotherapy for Prostate Cancer: A Single-Institution Matched-Pair Analysis. Int J Radiat Oncol Biol Phys 2009 (sous presse, epub ahead of print): http:\/\/dx.doi.org\/10.1016\/j.ijrobp.2009.01.081.","DOI":"10.1016\/j.ijrobp.2009.01.081"},{"key":"10.1016\/j.canrad.2009.08.144_bib33","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.juro.2008.03.133","article-title":"12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer","volume":"179","author":"Potters","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2009.08.144_bib34","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0360-3016(01)01578-4","article-title":"Potency after permanent prostate brachytherapy for localized prostate cancer","volume":"50","author":"Potters","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijrobp.2007.02.034","article-title":"Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients","volume":"69","author":"Prada","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brachy.2008.11.010","article-title":"Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients","volume":"8","author":"Prada","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2009.08.144_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-8140(03)00004-5","article-title":"Predictive factors of acute urinary morbidity after iodine-125\u00a0brachytherapy for localised prostate cancer: a phase 2\u00a0study","volume":"66","author":"Salem","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2009.08.144_bib38","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ijrobp.2005.08.042","article-title":"Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors","volume":"64","author":"Shah","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ijrobp.2005.09.005","article-title":"Disease-specific survival following the brachytherapy management of prostate cancer","volume":"64","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1538-4721(02)00017-X","article-title":"What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms","volume":"1","author":"Stock","year":"2002","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2009.08.144_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0302-2838(02)00019-2","article-title":"Complications following permanent prostate brachytherapy","volume":"41","author":"Stone","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2009.08.144_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.urology.2006.10.001","article-title":"Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125\u00a0prostate brachytherapy followed up for a minimum of 5\u00a0years","volume":"69","author":"Stone","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.canrad.2009.08.144_bib43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/01.ju.0000152558.63996.29","article-title":"Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer","volume":"173","author":"Stone","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2009.08.144_bib44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0360-3016(98)00451-9","article-title":"Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity","volume":"43","author":"Storey","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib45","doi-asserted-by":"crossref","unstructured":"Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS et al. Erectile function durability following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2009;75:639\u201348.","DOI":"10.1016\/j.ijrobp.2008.11.058"},{"key":"10.1016\/j.canrad.2009.08.144_bib46","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0022-5347(01)62542-4","article-title":"Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate","volume":"160","author":"Terk","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2009.08.144_bib47","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ijrobp.2005.03.046","article-title":"Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry","volume":"63","author":"Van Gellekom","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2008.09.008","article-title":"Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150","volume":"91","author":"Vordermark","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2009.08.144_bib49","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0360-3016(96)00570-6","article-title":"Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection","volume":"37","author":"Wallner","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JCO.1996.14.2.449","article-title":"Tumor control and morbidity following transperineal iodine 125\u00a0implantation for stage T1\/T2\u00a0prostatic carcinoma","volume":"14","author":"Wallner","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2009.08.144_bib51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0360-3016(02)03934-2","article-title":"Probability of late rectal morbidity in 125I prostate brachytherapy","volume":"55","author":"Waterman","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0360-3016(00)00550-2","article-title":"Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125\u00a0prostate implantation for patients with localized prostate cancer","volume":"47","author":"Zelefsky","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","article-title":"Multi-institutional analysis of long-term outcome for stages T1-T2\u00a0prostate cancer treated with permanent seed implantation","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.08.144_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijrobp.2006.08.030","article-title":"Five-year outcome of intraoperative conformal permanent I-125\u00a0interstitial implantation for patients with clinically localized prostate cancer","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321809003783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321809003783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:16:47Z","timestamp":1761135407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321809003783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1278321809003783"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2009.08.144","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curieth\u00e9rapie de prostate par iode 125\u00a0: facteurs pronostiques de longue dur\u00e9e de toxicit\u00e9 urinaire, digestive et sexuelle","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2009.08.144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}